Showing results (1211-1220 of 1,316) with videos related to

Sort By:
Pageof 132
PLOS Global Public Health|December 29, 2025
Task sharing for point-of-care testing: Review of national health policies and implementation landscape in 19 African countriesZibusiso Ndlovu, Mariamo Ibraimo Assane, Francis Ocen, et al.
British Journal of Anaesthesia|July 22, 2016
Covert stroke after non-cardiac surgery: a prospective cohort studyM Mrkobrada, M D Hill, M T V Chan, et al.
Genome Research|January 16, 2015
The Release 6 reference sequence of the Drosophila melanogaster genomeRoger A Hoskins, Joseph W Carlson, Kenneth H Wan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2025
Current clinical applications of AAV-mediated gene therapyBarry J Byrne, Kevin M Flanigan, Susan E Matesanz, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and fundingMargaret V Ragni, Guy Young, Glaivy Batsuli, et al.
Genome Biology|January 23, 2003
Finishing a whole-genome shotgun: release 3 of the Drosophila melanogaster euchromatic genome sequenceSusan E Celniker, David A Wheeler, Brent Kronmiller, et al.
Lancet (London, England)|July 18, 2017
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trialStephen Russell, Jean Bennett, Jennifer A Wellman, et al.
Journal Francais D'Ophtalmologie|February 18, 2026
Extension of the intravitreal injection interval after switching to faricimab in patients with exudative AMD: The multicenter FAR WEST studyA Posnic, M Vaast, A Poinas, et al.
Neuromuscular Disorders : NMD|September 26, 2025
Consensus recommendations and considerations for the delivery and monitoring of gene therapy in patients with Duchenne muscular dystrophyJodi M Wolff, Nora Capocci, Evrim Atas, et al.
Pageof 132